Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1126/science.285.5424.26
10.1126/science.285.5424.26 · External reference
10.7326/0003-4819-115-6-443
10.7326/0003-4819-115-6-443 · External reference
10.1056/nejm199208063270601
10.1056/nejm199208063270601 · External reference
10.3109/00365529209000103
10.3109/00365529209000103 · External reference
10.1002/hep.1840220211
10.1002/hep.1840220211 · External reference
10.1097/00042560-199802001-00003
10.1097/00042560-199802001-00003 · External reference
10.5694/j.1326-5377.1995.tb139937.x
10.5694/j.1326-5377.1995.tb139937.x · External reference
10.1093/oxfordjournals.bmb.a072408
10.1093/oxfordjournals.bmb.a072408 · External reference
10.1073/pnas.88.6.2451
10.1073/pnas.88.6.2451 · External reference
10.1016/0140-6736(90)90134-q
10.1016/0140-6736(90)90134-q · External reference
10.1016/0042-6822(91)90104-j
10.1016/0042-6822(91)90104-j · External reference
10.1073/pnas.87.24.9524
10.1073/pnas.87.24.9524 · External reference
A phylogenetically conserved stem‐loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap‐independent viral translation.
10.1128/jvi.73.2.1165-1174.1999 · 1999 · External reference
Stability of a stem‐loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA.
1996 · External reference
Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA.
10.1128/jvi.70.6.3363-3371.1996 · 1996 · External reference
10.1128/jvi.74.4.2046-2051.2000
10.1128/jvi.74.4.2046-2051.2000 · External reference
10.1073/pnas.88.13.5547
10.1073/pnas.88.13.5547 · External reference
Expression and identification of hepatitis C virus polyprotein cleavage products.
10.1128/jvi.67.3.1385-1395.1993 · 1993 · External reference
10.1099/0022-1317-80-12-3099
10.1099/0022-1317-80-12-3099 · External reference
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
10.1128/jvi.68.10.6147-6160.1994 · 1994 · External reference
Functional analysis of cell surface‐expressed hepatitis C virus E2 glycoprotein.
10.1128/jvi.73.8.6782-6790.1999 · 1999 · External reference
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
10.1128/jvi.73.8.6235-6244.1999 · 1999 · External reference
10.1126/science.282.5390.938
10.1126/science.282.5390.938 · External reference
10.1002/hep.510290356
10.1002/hep.510290356 · External reference
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.
10.1128/jvi.67.8.4665-4675.1993 · 1993 · External reference
Hepatitis C virus‐encoded NS2–3 protease: cleavage‐site mutagenesis and requirements for bimolecular cleavage.
10.1128/jvi.69.7.4127-4136.1995 · 1995 · External reference
Analysis of N‐terminal processing of hepatitis C virus nonstructural protein 2.
10.1128/jvi.68.4.2731-2734.1994 · 1994 · External reference
NS3 is a serine protease required for processing of hepatitis C virus polyprotein.
10.1128/jvi.67.7.4017-4026.1993 · 1993 · External reference
10.1073/pnas.90.22.10583
10.1073/pnas.90.22.10583 · External reference
Hepatitis C virus NS3 serine proteinase: trans‐cleavage requirements and processing kinetics.
10.1128/jvi.68.12.8147-8157.1994 · 1994 · External reference
10.1006/bbrc.1995.2447
10.1006/bbrc.1995.2447 · External reference
10.1006/bbrc.1996.1225
10.1006/bbrc.1996.1225 · External reference
Hepatitis C virus‐encoded nonstructural protein NS4A has versatile functions in viral protein processing.
10.1128/jvi.69.3.1575-1581.1995 · 1995 · External reference
Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.
10.1128/jvi.68.6.3753-3760.1994 · 1994 · External reference
10.1056/nejm199601113340203
10.1056/nejm199601113340203 · External reference
10.1172/jci118025
10.1172/jci118025 · External reference
10.1002/hep.510300405
10.1002/hep.510300405 · External reference
10.1002/hep.510290438
10.1002/hep.510290438 · External reference
10.1002/hep.510280630
10.1002/hep.510280630 · External reference
10.1002/j.1460-2075.1996.tb00329.x
10.1002/j.1460-2075.1996.tb00329.x · External reference
10.1055/s-2007-1007262
10.1055/s-2007-1007262 · External reference
10.1111/j.1440-1746.1997.tb00477.x
10.1111/j.1440-1746.1997.tb00477.x · External reference
10.1159/000150360
10.1159/000150360 · External reference
Genetic heterogeneity of the hepatitis C virus.
1995 · External reference
Biology and genetic heterogeneity of hepatitis C virus.
1995 · External reference
10.1099/0022-1317-74-11-2391
10.1099/0022-1317-74-11-2391 · External reference
10.1016/s0966-842x(00)89000-9
10.1016/s0966-842x(00)89000-9 · External reference
10.1007/bf00945022
10.1007/bf00945022 · External reference
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.
10.1128/jvi.66.5.3225-3229.1992 · 1992 · External reference
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.
10.1128/jvi.66.5.3225-3229.1992 · 1992 · External reference
10.1016/0042-6822(92)90933-g
10.1016/0042-6822(92)90933-g · External reference
Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.
10.1128/jvi.67.7.3923-3930.1993 · 1993 · External reference
10.1073/pnas.89.8.3468
10.1073/pnas.89.8.3468 · External reference
Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection.
10.1128/jvi.72.3.1725-1730.1998 · 1998 · External reference
10.1002/hep.510250231
10.1002/hep.510250231 · External reference
10.1002/hep.1840200507
10.1002/hep.1840200507 · External reference
10.1002/hep.1840220106
10.1002/hep.1840220106 · External reference
10.1002/(sici)1096-9071(199607)49:3<242::aid-jmv14>3.0.co;2-e
10.1002/(sici)1096-9071(199607)49:3<242::aid-jmv14>3.0.co;2-e · External reference
10.1111/j.1365-2893.1995.tb00040.x
10.1111/j.1365-2893.1995.tb00040.x · External reference
10.1016/s0950-3528(96)90007-x
10.1016/s0950-3528(96)90007-x · External reference
10.1046/j.1440-1746.1999.01846.x
10.1046/j.1440-1746.1999.01846.x · External reference
10.1056/nejm199904223401602
10.1056/nejm199904223401602 · External reference
10.1136/gut.44.4.563
10.1136/gut.44.4.563 · External reference
10.1056/nejm199909163411202
10.1056/nejm199909163411202 · External reference
10.1056/nejm199506013322202
10.1056/nejm199506013322202 · External reference
10.1002/hep.510260233
10.1002/hep.510260233 · External reference
10.1002/hep.510280238
10.1002/hep.510280238 · External reference
10.1016/s0140-6736(96)07642-8
10.1016/s0140-6736(96)07642-8 · External reference
10.1002/hep.510280632
10.1002/hep.510280632 · External reference
10.1053/gast.1997.v112.pm9024300
10.1053/gast.1997.v112.pm9024300 · External reference
10.1016/0168-8278(91)90841-x
10.1016/0168-8278(91)90841-x · External reference
10.1016/s0168-8278(98)80339-5
10.1016/s0168-8278(98)80339-5 · External reference
Progression of hepatitis B and C to hepatocellular carcinoma in Western countries.
1998 · External reference
10.1056/nejm199211193272104
10.1056/nejm199211193272104 · External reference
The association of hepatitis C virus with mixed cryoglobulinemia.
1994 · External reference
10.1093/rheumatology/32.8.689
10.1093/rheumatology/32.8.689 · External reference
10.1111/j.1365-2249.1992.tb03001.x
10.1111/j.1365-2249.1992.tb03001.x · External reference
Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas.
1995 · External reference
10.1111/j.1365-2249.1993.tb03449.x
10.1111/j.1365-2249.1993.tb03449.x · External reference
10.1016/0016-5085(94)90022-1
10.1016/0016-5085(94)90022-1 · External reference
Hepatitis C virus infection and cryoglobulinaemia.
1998 · External reference
10.1016/0016-5085(93)90862-7
10.1016/0016-5085(93)90862-7 · External reference
10.1016/s0168-8278(99)80239-6
10.1016/s0168-8278(99)80239-6 · External reference
Hepatitis C virus infection and clonal B‐cell expansion.
1996 · External reference
10.1159/000171547
10.1159/000171547 · External reference
10.1056/nejm199302183280703
10.1056/nejm199302183280703 · External reference
10.1002/hep.510290224
10.1002/hep.510290224 · External reference
10.3109/10428199809057606
10.3109/10428199809057606 · External reference
10.1111/j.1365-2141.1994.tb05036.x
10.1111/j.1365-2141.1994.tb05036.x · External reference
10.1016/0959-8049(94)90066-3
10.1016/0959-8049(94)90066-3 · External reference
10.1159/000203597
10.1159/000203597 · External reference
10.1046/j.1365-2141.1996.6912313.x
10.1046/j.1365-2141.1996.6912313.x · External reference
10.1007/s007050050100
10.1007/s007050050100 · External reference
10.1159/000168874
10.1159/000168874 · External reference
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
10.1681/asn.v461288 · 1993 · External reference
10.1016/s0002-9343(99)00014-5
10.1016/s0002-9343(99)00014-5 · External reference
10.1159/000168641
10.1159/000168641 · External reference
10.1056/nejm198612183152503
10.1056/nejm198612183152503 · External reference
10.1046/j.1440-1746.1999.01875.x
10.1046/j.1440-1746.1999.01875.x · External reference
Ten year follow‐up of patients with chronic hepatitis C treated with interferon.
1999 · External reference
10.1002/hep.1840150607
10.1002/hep.1840150607 · External reference
10.1016/s0168-8278(05)80438-6
10.1016/s0168-8278(05)80438-6 · External reference
10.1056/nejm199811193392101
10.1056/nejm199811193392101 · External reference
10.1002/hep.510260334
10.1002/hep.510260334 · External reference
10.1002/(sici)1097-0142(19990501)85:9<1943::aid-cncr10>3.0.co;2-f
10.1002/(sici)1097-0142(19990501)85:9<1943::aid-cncr10>3.0.co;2-f · External reference
10.1002/hep.510260701
10.1002/hep.510260701 · External reference
10.1016/s0140-6736(98)07236-5
10.1016/s0140-6736(98)07236-5 · External reference
10.1002/hep.510290439
10.1002/hep.510290439 · External reference
10.1023/a:1026601904609
10.1023/a:1026601904609 · External reference
10.1002/hep.510290424
10.1002/hep.510290424 · External reference
A controlled study to determine the optimal dose regimen of interferon‐alpha 2b in chronic hepatitis C.
1995 · External reference
10.1016/0168-8278(95)80052-2
10.1016/0168-8278(95)80052-2 · External reference
10.1007/bf02087883
10.1007/bf02087883 · External reference
10.1002/hep.1840190204
10.1002/hep.1840190204 · External reference
10.1002/hep.510240405
10.1002/hep.510240405 · External reference
10.1111/j.1572-0241.1998.172_b.x
10.1111/j.1572-0241.1998.172_b.x · External reference
10.1002/hep.510260637
10.1002/hep.510260637 · External reference
10.1046/j.1365-2893.1998.00114.x
10.1046/j.1365-2893.1998.00114.x · External reference
10.1046/j.1365-2036.1998.00328.x
10.1046/j.1365-2036.1998.00328.x · External reference
10.1002/hep.510280533
10.1002/hep.510280533 · External reference
10.1016/s0168-8278(99)80253-0
10.1016/s0168-8278(99)80253-0 · External reference
10.1016/0016-5085(93)90727-t
10.1016/0016-5085(93)90727-t · External reference
10.1016/s0140-6736(98)07124-4
10.1016/s0140-6736(98)07124-4 · External reference
10.1002/hep.510260719
10.1002/hep.510260719 · External reference
Safety of combination interferon alfa‐2b/ribavirin therapy in chronic hepatitis C‐relapsed and treatment‐naive patients.
1999 · External reference
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
1995 · External reference
Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.
1999 · External reference
10.1016/s0168-8278(99)80061-0
10.1016/s0168-8278(99)80061-0 · External reference
10.1002/hep.510260721
10.1002/hep.510260721 · External reference
10.1053/gast.1999.0029900408
10.1053/gast.1999.0029900408 · External reference
10.1056/nejm199811193392102
10.1056/nejm199811193392102 · External reference
10.1016/s0168-8278(99)80157-3
10.1016/s0168-8278(99)80157-3 · External reference
Combination treatment with interferon alfa‐2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
1995 · External reference
10.1002/jmv.1890460110
10.1002/jmv.1890460110 · External reference
10.1016/s0168-8278(99)80130-5
10.1016/s0168-8278(99)80130-5 · External reference
10.1111/j.1478-3231.1999.tb00049.x
10.1111/j.1478-3231.1999.tb00049.x · External reference
10.1097/00004836-199712000-00013
10.1097/00004836-199712000-00013 · External reference
10.1046/j.1365-2036.1999.00581.x
10.1046/j.1365-2036.1999.00581.x · External reference
10.1093/ndt/14.6.1558
10.1093/ndt/14.6.1558 · External reference
10.1002/hep.510230404
10.1002/hep.510230404 · External reference
10.1056/nejm199608293350904
10.1056/nejm199608293350904 · External reference
10.1111/j.1365-2796.1993.tb00734.x
10.1111/j.1365-2796.1993.tb00734.x · External reference
Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C.
1991 · External reference
10.1016/s0140-6736(96)90212-3
10.1016/s0140-6736(96)90212-3 · External reference
10.1016/0140-6736(93)90210-8
10.1016/0140-6736(93)90210-8 · External reference
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF‐induced apoptosis.
10.1128/jvi.72.5.3691-3697.1998 · 1998 · External reference
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin‐beta receptor.
10.1128/jvi.71.2.1301-1309.1997 · 1997 · External reference
10.1074/jbc.273.4.2256
10.1074/jbc.273.4.2256 · External reference
Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
10.1128/jvi.73.8.6506-6516.1999 · 1999 · External reference
10.1038/2053
10.1038/2053 · External reference
10.1056/nejm198911303212202
10.1056/nejm198911303212202 · External reference
10.1056/nejm199412153312402
10.1056/nejm199412153312402 · External reference
10.1126/science.1279801
10.1126/science.1279801 · External reference
10.1073/pnas.91.16.7792
10.1073/pnas.91.16.7792 · External reference
10.1073/pnas.93.5.1759
10.1073/pnas.93.5.1759 · External reference
10.1002/hep.510280429
10.1002/hep.510280429 · External reference
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.
10.1128/jvi.68.3.1494-1500.1994 · 1994 · External reference
10.1016/s0016-5085(99)70237-4
10.1016/s0016-5085(99)70237-4 · External reference
10.1016/0952-7915(91)90005-l
10.1016/0952-7915(91)90005-l · External reference
10.1016/s0065-2776(08)60030-9
10.1016/s0065-2776(08)60030-9 · External reference
10.1002/jmv.1890450406
10.1002/jmv.1890450406 · External reference
10.1172/jci118842
10.1172/jci118842 · External reference
10.1016/s0140-6736(95)91691-1
10.1016/s0140-6736(95)91691-1 · External reference
Immunodominant CD4+ T‐cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.
10.1128/jvi.71.8.6011-6019.1997 · 1997 · External reference
10.1016/s0016-5085(99)70353-7
10.1016/s0016-5085(99)70353-7 · External reference
10.1002/hep.510300435
10.1002/hep.510300435 · External reference
10.1034/j.1600-0528.2002.017403.x
10.1034/j.1600-0528.2002.017403.x · External reference
10.1007/bf00945025
10.1007/bf00945025 · External reference
10.1111/j.1365-2893.1997.tb00178.x
10.1111/j.1365-2893.1997.tb00178.x · External reference
The role of hepatitis C virus‐specific cytotoxic T lymphocytes in chronic hepatitis C.
10.4049/jimmunol.158.3.1473 · 1997 · External reference
10.1016/s0950-3528(96)90054-8
10.1016/s0950-3528(96)90054-8 · External reference
10.1172/jci119308
10.1172/jci119308 · External reference
10.1016/s1074-7613(00)80044-8
10.1016/s1074-7613(00)80044-8 · External reference
Hepatitis C virus‐specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
10.4049/jimmunol.151.8.4189 · 1993 · External reference
Hepatitis C virus (HCV)‐specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
10.1128/jvi.67.12.7522-7532.1993 · 1993 · External reference
10.1172/jci118287
10.1172/jci118287 · External reference
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus‐encoded peptides binding to HLA‐A2.1 molecules.
10.1128/jvi.69.4.2462-2470.1995 · 1995 · External reference
10.1172/jci119778
10.1172/jci119778 · External reference
10.1073/pnas.92.7.2755
10.1073/pnas.92.7.2755 · External reference
10.1006/viro.1997.8674
10.1006/viro.1997.8674 · External reference
Direct visualization of hepatitis C virus‐spcific cytotoxic T Cells using peptide‐MHC tetramers and analysis of aminoacid variations within the viral epitope.
1999 · External reference
Differential cytotoxic T‐lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.
10.1128/jvi.70.10.7092-7102.1996 · 1996 · External reference
10.1002/hep.510250336
10.1002/hep.510250336 · External reference
10.1016/s0016-5085(98)70268-9
10.1016/s0016-5085(98)70268-9 · External reference
10.1016/0952-7915(95)80098-0
10.1016/0952-7915(95)80098-0 · External reference
Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus‐specific CD4+ T cells.
10.4049/jimmunol.163.2.650 · 1999 · External reference
10.1172/jci117893
10.1172/jci117893 · External reference
10.1002/hep.1840190606
10.1002/hep.1840190606 · External reference
10.1073/pnas.96.10.5692
10.1073/pnas.96.10.5692 · External reference
Perforin, Fas/Fas ligand, and TNF‐alpha pathways as specific and bystander killing mechanisms of hepatitis C virus‐specific human CTL.
10.4049/jimmunol.158.11.5283 · 1997 · External reference
10.1002/hep.510240402
10.1002/hep.510240402 · External reference
10.1136/gut.46.2.260
10.1136/gut.46.2.260 · External reference
10.1016/s0016-5085(97)70235-x
10.1016/s0016-5085(97)70235-x · External reference
10.1016/0016-5085(94)90550-9
10.1016/0016-5085(94)90550-9 · External reference
Chemokine receptors and T cell chemotaxis [comment].
10.1084/jem.184.3.799 · 1996 · External reference
10.1084/jem.187.1.129
10.1084/jem.187.1.129 · External reference
Expression of IFN‐inducible protein‐10 in chronic hepatitis.
10.4049/jimmunol.158.11.5536 · 1997 · External reference
Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C‐infected liver.
10.4049/jimmunol.163.11.6236 · 1999 · External reference
10.1002/hep.510240102
10.1002/hep.510240102 · External reference
10.1016/s0168-8278(97)80409-6
10.1016/s0168-8278(97)80409-6 · External reference
T1 vs T2 cytokine responses in chronic HCV: Implications for mechanisms of liver injury.
1997 · External reference
10.1172/jci115723
10.1172/jci115723 · External reference
10.1016/0016-5085(92)91129-r
10.1016/0016-5085(92)91129-r · External reference
10.1056/nejm199603283341302
10.1056/nejm199603283341302 · External reference
Hepatitis C infection in liver transplant patients.
1992 · External reference
10.1002/hep.510290412
10.1002/hep.510290412 · External reference
10.1002/hep.510250137
10.1002/hep.510250137 · External reference
10.1016/s0016-5085(99)70454-3
10.1016/s0016-5085(99)70454-3 · External reference
10.1002/hep.510280333
10.1002/hep.510280333 · External reference
10.1097/00007890-199603270-00007
10.1097/00007890-199603270-00007 · External reference
10.1097/00007890-199808270-00010
10.1097/00007890-199808270-00010 · External reference
10.1002/hep.510290123
10.1002/hep.510290123 · External reference
10.1016/s0272-6386(97)90345-0
10.1016/s0272-6386(97)90345-0 · External reference
Prevalence and outcome of hepatitis C infection among heart transplant recipients.
1995 · External reference
10.1097/00007890-199110000-00013
10.1097/00007890-199110000-00013 · External reference
10.1016/s0041-1345(96)00312-0
10.1016/s0041-1345(96)00312-0 · External reference
10.1002/hep.510300519
10.1002/hep.510300519 · External reference
10.1002/hep.510290609
10.1002/hep.510290609 · External reference
Long‐term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
10.1182/blood.v86.4.1614.bloodjournal8641614 · 1995 · External reference
Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti‐HCV‐positive blood donors.
1996 · External reference
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation [see comments].
1997 · External reference
10.1016/s0168-8278(98)80224-9
10.1016/s0168-8278(98)80224-9 · External reference
10.1002/hep.510290122
10.1002/hep.510290122 · External reference
Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
1999 · External reference
10.1053/gast.1996.v110.pm8536853
10.1053/gast.1996.v110.pm8536853 · External reference
Persistent hepatitis C virus infection after liver transplantation: clinical and virological features.
1995 · External reference
10.1002/lt.500040102
10.1002/lt.500040102 · External reference
10.1016/0016-5085(95)90207-4
10.1016/0016-5085(95)90207-4 · External reference
10.1002/hep.510240510
10.1002/hep.510240510 · External reference
10.1016/s0016-5085(94)95829-7
10.1016/s0016-5085(94)95829-7 · External reference
10.1002/hep.510230505
10.1002/hep.510230505 · External reference
10.1002/lt.500040401
10.1002/lt.500040401 · External reference
Immunopathogenesis of hepatitis B and hepatitis C infection in the nonimmunosuppressed and immuno‐suppressed state.
1999 · External reference
10.1016/s0168-8278(00)80199-3
10.1016/s0168-8278(00)80199-3 · External reference
10.1111/j.1399-0039.1998.tb03070.x
10.1111/j.1399-0039.1998.tb03070.x · External reference
10.1016/s0016-5085(99)70352-5
10.1016/s0016-5085(99)70352-5 · External reference
10.1002/hep.510260331
10.1002/hep.510260331 · External reference
10.1097/00007890-199901150-00013
10.1097/00007890-199901150-00013 · External reference
10.1002/hep.510300314
10.1002/hep.510300314 · External reference
10.1093/ndt/10.supp6.129
10.1093/ndt/10.supp6.129 · External reference
10.1016/s0041-1345(97)00405-3
10.1016/s0041-1345(97)00405-3 · External reference
10.1097/00007890-199910270-00012
10.1097/00007890-199910270-00012 · External reference
10.1002/hep.1840200402
10.1002/hep.1840200402 · External reference
Alpha‐interferon for acute hepatitis C in liver transplant patients.
1995 · External reference
10.1002/hep.1840220411
10.1002/hep.1840220411 · External reference
10.1002/hep.510270530
10.1002/hep.510270530 · External reference
10.1111/j.1432-2277.1995.tb01709.x
10.1111/j.1432-2277.1995.tb01709.x · External reference
10.1097/00007890-199605270-00013
10.1097/00007890-199605270-00013 · External reference
New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
1995 · External reference
10.1002/hep.510260236
10.1002/hep.510260236 · External reference
10.1002/hep.510260238
10.1002/hep.510260238 · External reference
10.1016/s0041-1345(96)00248-5
10.1016/s0041-1345(96)00248-5 · External reference
10.1097/00000658-199906000-00009
10.1097/00000658-199906000-00009 · External reference
10.1002/lt.500030205
10.1002/lt.500030205 · External reference
10.1097/00007890-199709270-00015
10.1097/00007890-199709270-00015 · External reference
10.3109/00365599609182328
10.3109/00365599609182328 · External reference
Recombinant 3alpha‐interferon in renal allograft recipients with chronic hepatitis C.
1995 · External reference
10.1038/ki.1994.346
10.1038/ki.1994.346 · External reference
10.1056/nejm199209243271302
10.1056/nejm199209243271302 · External reference
10.1093/ndt/10.supp1.58
10.1093/ndt/10.supp1.58 · External reference
10.1097/00007890-199403270-00010
10.1097/00007890-199403270-00010 · External reference
10.1016/s0016-5085(99)70561-5
10.1016/s0016-5085(99)70561-5 · External reference
10.1006/viro.1996.0297
10.1006/viro.1996.0297 · External reference
